A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study - Concepedia

Concepedia

Publication | Closed Access

A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

882

Citations

12

References

2009

Year

Geeta A. Lalwani, Philip J. Rosenfeld, Anne E. Fung, Sander R. Dubovy, S. Michels, William J. Feuer, Janet L. Davis, Harry W. Flynn, Maria Esquiabro

American Journal of Ophthalmology

Ocular DiseaseVitreous BodyOphthalmologyVariable-dosing RegimenPronto StudyAge-related DiseasesNeurologyGlaucomaOcular PathologyMedicineIntravitreal Ranibizumab

References

	Year	Citations

Page 1

Page 1